Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Patent Application: Sigmari Ligand for Pancreatic Cancer Treatment

The USPTO has published a patent application (US20260083725A1) for a Sigmari Ligand for the treatment of pancreatic cancer. The application details a method involving a Sig-1R ligand to inhibit tumor growth and metastasis, filed on August 9, 2023.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Cancer Treatment Methods Using Tumor Treating Fields, Chemotherapy, and Anti-Fibrotic Agents

The USPTO has published a patent application detailing methods for treating cancer. The application describes compositions and systems involving the concurrent application of tumor treating fields, chemotherapeutic agents, and anti-fibrotic agents to reduce cancer cell viability and tumor growth.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

Biopolymers for Ophthalmic Use Patent Application

The USPTO has published a patent application (US20260083771A1) for biopolymers intended for ophthalmic use, filed by ExoPolymer, Inc. The application details biopolymers comprising repeating polysaccharide units, their preparations, ophthalmic compositions, and methods of use.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Fiber-Based Prebiotic Dietary Supplements

The USPTO has published a patent application (US20260083772A1) for powder compositions comprising fiber intended for use as a prebiotic dietary supplement. The application details therapeutic ingredients and manufacturing processes aimed at improving gut microbiome and overall gut health.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Pegylated Menaquinol Compositions and Treatment Methods Patent Application

The USPTO has published a patent application (US20260083773A1) for pegylated menaquinol compositions and methods of treatment. The application, filed on December 5, 2025, discloses isolated, stable, and biologically active pegylated menaquinol derivatives for treating various diseases.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application: Acetic Acid and Hypochlorous Acid Compositions for Skin Trauma Treatment

The USPTO has published a new patent application (US20260083774A1) detailing compositions containing hypochlorous acid and acetic acid for treating skin trauma and biofilms. The application was filed on September 22, 2025, and published on March 26, 2026.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Metal nanoparticle agglomerates for infection control and water purification

The USPTO has published a patent application detailing the use of metal nanoparticle agglomerates for infection control and water purification. The application describes antiseptic substrates and fluid formulations incorporating these agglomerates for topical or oral use, aiming to provide infection control against infective agents.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

Patent Application: Cytotoxic Lymphocyte Activation and Expansion

The USPTO has published patent application US20260083776A1 concerning methods for activating and expanding cytotoxic lymphocytes with decreased exhaustion potential. The application details micropatterned surfaces and biofunctionalization techniques for cell expansion, potentially impacting future therapeutic development in oncology.

Routine Notice Healthcare
Favicon for changeflow.com

Patent Application: Systems for ordering from electronic menu and servicing

The USPTO has published a new patent application, US20260087541A1, detailing systems, apparatuses, and methods for ordering items from an electronic menu and servicing thereof. The application was filed on December 3, 2025, by inventors Yu FANG, Robert R. DYKES, and Heidi GIBSON.

Routine Notice Intellectual Property
Favicon for changeflow.com

USPTO Patent Application: Electronic Devices Precluding User Interaction

The USPTO has published a patent application (US20260087542A1) detailing electronic devices and systems designed to preclude user interaction events in e-commerce environments. The application describes a method for detecting potential fraud by analyzing device activity and, if a fraud propensity score exceeds a threshold, blocking certain user interactions like shopping cart modifications.

Routine Notice Cybersecurity

Showing 3861–3870 of 32,310 changes

1 385 386 387 388 389 3231

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.